Expert Insights
Channels
ETF Strategist
Fixed Income
Active ETF
Free Cash Flow
Alternatives
Future ETFs
Beyond Basic Beta
Global Diversification
China Insights
Gold & Silver Investing
Climate Insights
Innovative ETFs
Commodities
Institutional Income Strategies
Core Strategies
Leveraged & Inverse
Crypto
Managed Futures
Disruptive Technology
Megatrends
Dividend
Modern Alpha
Dual Impact
Multi-Asset
Education
Portfolio Strategies
Emerging Markets
Retirement Income
Energy Infrastructure
Thematic Investing
ESG
Volatility Resource
ETF Building Blocks
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
First Bitcoin ETF
Newsletter
New ETFs
ETF Ecosystem
Education Central
ETF Playbook
ETFinTwit
Videos & Podcasts
Videos
ETF of the Week
ETF Prime Podcast
ETF 360 Video Series
Podcasts
Events
Exchange: An ETF Experience
Salix
Featured
Salix Bidding War Provides Modest Boost for Pharma ETFs
By
Todd Shriber
March 11, 2015
X